Avantor, Inc.
Avantor is a provider of mission-critical products and services to the life sciences and advanced technology industries, with a strong bullish signal driven by a cluster of 5 director-level insider buys totaling $7.27M in the last 180 days and a holding by former President Donald J. Trump.
BusinessWhat AVTR does
Avantor supplies essential materials, consumables, and equipment to customers in the biopharma, healthcare, education, government, and advanced technology sectors. Its revenue is derived from product sales and service offerings that support research, development, and production workflows. The company operates globally, serving as a key infrastructure partner for laboratory and production facilities.
12 months past · 3 months futureAVTR activity timeline
Executive Branch ConflictsAVTR held by Trump-administration officials
Lifetime Government AwardsAVTR federal contracts
AVTR doesn't hold direct federal contracts.
Verified via USASpending.gov: $0 reported in direct prime-contract awards. Companies in this position typically sell federal services indirectly through prime contractors and integrators (e.g., Lockheed Martin, Booz Allen, Microsoft Azure) or through commercial channels that don't appear in USASpending data.
Politicians Trading AVTRMembers of Congress with recent AVTR positions
Congressional TradesWho in Congress is trading AVTR
Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock
Stock awards & option exercises
Bills Affecting AVTRLive legislation impacting this stock
Political ProfileWhere AVTR sits in Washington
[object Object]
STRUCTURAL: Minimal direct political infrastructure (0 lobbying spend, 0 donations). EVIDENTIARY: Strong cluster of 5 insider buys by 4 distinct directors within 180 days totaling $7.27M (`get_corporate_insider_signal.total_dollar_volume`), and a holding of common stock by former President Donald J. Trump (`get_executive_branch_exposure.by_ticker[0].holdings[0].filer`). Net: Evidentiary signals from high-level insiders and executive branch exposure dominate the neutral structural profile.
Regulatory ExposureThreats & opportunities
Regulatory threats
-
Heightened legislative scrutiny on healthcare pricing and supply chainsU.S. Congress"8 recent bills in `Recent bill_impacts` all target the healthcare sector with consistent estimated revenue impacts averaging ~$4.9M."
Regulatory opportunities
- No specific regulatory opportunities flagged.
Live signals + predictions for AVTR — for Founders
The free page above gives you the public record. Members see the real-time intelligence layer on top of it:
- Live 7-layer signal scores when Congress trades AVTR
- Bill Pass Index v2 odds for every bill on the watch list
- Iron Triangle alerts (committee × donor × trade)
- SEC Form 4 cluster detection (CEO + CFO + director buys)
- Whale-Opportunity expected-value ranking
- Custom watchlist alerts via email + Discord